Search - tctmd.com

Displaying 201 - 220 of 262

Sort: Relevancy | Date

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

Presentation EuroPCR 2012

A Randomized Comparison Between Everolimus- and Sirolimus-eluting Stent in Chronic Coronary Total Occlusions: Final Results of the CIBELES Trial

Presenter: 13956|Raul Moreno

May 18, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

Presentation ACC 2012

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Presenter: Robert A. Byrne

March 24, 2012

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

Jason Kahn

March 06, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

Presentation

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Presenter: 202206|M Natsuaki

March 04, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

Presentation

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Presenter: Takeshi Kimura

January 08, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

Presentation TCT 2012

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Satoshi Shizuta, Toru Kita, Takeshi Kimura

January 03, 2012

Presentation TCT 2012

Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model

Presenter: Li Shen, Qibing Wang, Yizhe Wu, Jian Xie, Junbo Ge

January 03, 2012

Advertisement

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

A Randomized Comparison Between Everolimus- and Sirolimus-eluting Stent in Chronic Coronary Total Occlusions: Final Results of the CIBELES Trial

CIBELES: Xience Stands Up to Cypher for CTO PCI

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

SES Effective for Both Focal, Diffuse DES Restenosis

TCTMD’s Top 10 Most Popular News Stories From 2011

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

Statins Reduce Late Restenosis After SES Implantation

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content